Document is current
Any future updates will be listed below
-
Authors
Schönenberg, Aline
Santos García, Diego
Mir, Pablo
Wu, Jian-Jun
Heimrich, Konstantin G.
Mühlhammer, Hannah M.
Prell, Tino
-
Funding
Funding for this research was provided by:
UCB Pharma
Italfarmaco
Teva Pharmaceutical Industries
AbbVie
Ministerio de Ciencia e Innovación (RTC2019-007150-1)
Instituto de Salud Carlos III (PI18/01898)
Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía (CVI-02526, CTS-7685)
Consejería de Salud y Bienestar Social, Junta de Andalucía (PI-0471-2013, PE-0210-2018, PI-0459-2018, PE-0186-2019)
Fundación Alicia Koplowitz
National Health Commission of the People's Republic of China (Pro20211231084249000238)
Science and Technology Commission of Shanghai Municipality (2018SHZDZX01, 21S31902200)
Bundesministerium für Bildung und Forschung (01GY1804)
Bundesministerium für Bildung und Forschung (01GY1804)
Universitätsklinikum Halle (Saale)
- License Information
-
More Information
Article History
Received: 16 May 2022
Accepted: 29 April 2023
First Online: 3 May 2023
Competing interests
: The Authors declare no competing non-financial interests but report the following financial disclosures: AS and KH report no disclosures. DSG received honoraria for educational presentations and advice service by Abbvie, UCB Pharma, Lundbeck, KRKA, Zambon, Bial, Italfarmaco, and Teva. PM has received grants by the Fundación Alicia Koplowitz and also received support for attending meetings and/or travel or honorarium for lecturing from Abbott, Allergan, Abbvie. Bial, Britannia, Italfarmaco, Merz, UCB, Teva and Zambon.
